Summary of Role
As Scientific Officer you will work together with the Centre for Molecular Pathology, which provides molecular diagnostic testing for patients, so that research can quickly be converted into improved diagnosis and treatments. You will work in a team with other scientific officers and will contribute to expand our highest standard bio-banking activities for National trials and to develop novel molecular diagnostic tests and help transfer these into clinically applicable diagnostic tools.
Key Requirements
The successful candidate must hold a BSc in biological subject and ideally have experience of working to good laboratory practice & standard safety rules. Basic knowledge of computers that includes databases and word-processing is essential as well as experience with molecular biology techniques. Experience with massively parallel sequencing, flow cytometry or primary cell culture would be an advantage. Knowledge of a diagnostic laboratory would also be advantageous.
Department/Directorate Information
The Haemato-Oncology Research Unit is involved in a number of ground-breaking phase I, II and III clinical trials in myeloma and leukaemia, as well as being the central laboratory for scientific studies linked to a number of national clinical studies (including MRC, CRUK, and Myeloma UK funded studies).
Anti-cancer drug development has changed significantly in adult oncology, with the introduction of targeted agents. Treatment of adults with cancer has moved away from the concept of a ‘one size fits all’ to a more tailored and personalised approach. This approach ensures that the molecular profile of the patient’s tumour is determined so that the most appropriate drugs are used.
The Division of Genetics and Epidemiology is led by Prof Richard Houlston, FRS, with whose team the Myeloma Molecular Therapy/Kaiser team is closely integrated. The Division is internationally renowned for its pioneering work in understanding the underlying genetic causes of cancer risk. High-quality laboratory, epidemiological and clinical research within the division is driven by energetic, innovative leadership and complemented by participation in national and international research consortiums, clinical collaborations and technological partnerships.
We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Dr Martin Kaiser via email on [email protected]